.jpg)
Our mission At Aquilo, it is our mission to provide contract research services within the respiratory field. We perform efficacy analyses of existing and novel therapies for lung diseases. Being a spin-off company from the University of Groningen, Aquilo benefits from close interaction with the University, as well as the University Medical Center Groningen and other contract research organizations (CRO’s). Please have a look at our portfolio on our own website or contact us (info@aquilo.nl) to see how our expertise can help you with the development of your therapy. Website: www.aquilo.nl
Ardena Assen offers its services to the pharmaceutical industry and veterinary industry. It is active in all phases of pharmaceutical development and is a Good Laboratory Pratices (GLP) compliant laboratory, inspected by the Dutch authorities on a regular bases. Ardena Assen possesses the most advanced analysis techniques for both chromatographic assays and immunochemistry assays. Website: www.ardena.com
Encapsulation inside microbubbles. This means encapsulating the active within a shell of gas. This shell of gas is a perfect barrier against leakage of the active as long as the active is non-volatile (which is the case for most relevant actives). However, just like soap bubbles our microbubbles can also be made to ‘pop’ and this instantaneously and completely releases the drug. This popping can be made to happen in response to triggers such as pH, osmotic pressure, shear or ultrasound making microbubble-encapsulation a very versatile and widely applicable technology. Other advantages of the technology include the use of a very small amount of excipients (since our main excipient is gas) and the fact that the barrier and release properties of the microbubbles do not depend on physicochemical properties of the active to be encapsulated. This ensures a short time-to-market. Website: www.bether-encapsulates.nl
BiomACS (Biomaterial Advanced Cell Screening) specializes in improving the interaction between the human body and implants. With our unique screening technology, we can quickly and accurately test how human cells respond to different materials, a process that traditionally takes years, but with us only takes a few days. Our expertise lies at the intersection of materials science, chemistry, cell biology, and clinical practice. Thanks to this multidisciplinary approach, we support the medical industry in developing safer, higher-performing, and more personalized medical devices. BiomACS provides screening services for manufacturers of implants such as prostheses, stents, catheters, and intraocular lenses. Our technology helps them achieve better designs faster and reduce complications such as rejection or infection. In this way, we contribute to a higher quality of life for patients worldwide. ( www.biomacs.nl )
Our proprietary coating technology efficiently kills bacteria upon contact, without being at risk to elicit bacterial resistance. We can apply our coating on PDMS and on titanium substrates, but our technology has potential for a variety of other materials. Our initial focus is on titanium orthopedic trauma materials (e.g., pins and plates) and urinary catheters (PDMS). Future applications include most indwelling medical devices. Website: https://bioprexmedical.com/
Biotrack/NL-Lab are specialized in microbioligical research. We develop tools for gutmicrobiome analyses, antibiotics susceptibility testing using our patented C-FISH technology. Our technology focuses on function and activity of micro-organisms. We work from our own, fully equipped microbiological laboratory in Leeuwarden with a BSL 2 and 3 level.
The products and services they provide are categorized into four key pillars: Colocation (optimally conditioned computer rooms with redundant (emergency) power supplies), Connectivity (connections between locations, data centers, the internet, and public cloud services), Cloud (private cloud, partner clouds, and hybrid cloud solutions integrating public cloud providers), and HPC (modular and scalable high-performance data processing, storage, and distribution). Our HPC platform and its related HPC ecosystem enable businesses and public organizations to utilize these functionalities without requiring large investments or over-dimensioning their own IT infrastructure. 100% Dutch in terms of ownership, structure, locations, and compliance with national laws and regulations. Bytesnet Groningen Bytesnet is also rooted in Groningen , located on the Campus Groningen . In 2018, we opened our advanced data center with an innovative Data Lab on Campus Groningen. Here, in addition to colocation and high-performance computing , we provide collaborative spaces for students and businesses. The data center is fully redundant in terms of power supply, cooling, and security . Because d’ROOT functions as the next-generation data center , it is designed for sustainability and high-performance computing for big data . It offers more computing capacity with responsible energy consumption and maximized reuse of waste heat. We are already operating on 100% green energy . Website: Bytesnet
In a recent clinical validation study using samples from the Dutch National Screening Program, the Methica CC Kit achieved 97% sensitivity in cancer detection without compromising specificity. This study, conducted across multiple centers, reflects real-world performance and marks a significant advancement in cervical cancer diagnostics. CC Diagnostics is headquartered in Groningen, Netherlands, and collaborates with various partners, including the University Medical Centre Groningen (UMCG) and IQ Products. Their mission is to empower women by providing optimal cervical cancer screening that is accurate, accessible, and comfortable.
.jpg)
Recently, the LIFE Cooperative, together with the University Medical Center Groningen (UMCG), has been working hard on submitting projects to PharmaNL.
From 2026 onwards, SpringBoard, the industry association for medical technology, will continue as part of LIFE Cooperative. This is a logical step, as both organizations pursue the same goals for their members. With this integration, the knowledge, experience, and network of SpringBoard will become part of LIFE Cooperative — the cooperative of more than 60 Northern Dutch Life Science companies. This marks an important step toward strengthening and further growing the Life Science & Health sector in the Northern Netherlands. “We complement each other perfectly and are even stronger together. By joining forces in this way, we increase the effectiveness of the solutions developed to contribute to sustainable healthcare. In doing so, we create economic opportunities for our members!” — Ronald Hesse, Director of LIFE Cooperative Joint ambition Since its founding in 2014, LIFE Cooperative has worked closely and enthusiastically with SpringBoard. On behalf of SpringBoard, Jan Thalens has played an important role in this collaboration by contributing to the further development of the cooperative as a member of LIFE Cooperative’s board. In 2025, SpringBoard decided it was time for the next step. LIFE Cooperative shares this ambition and will further expand its activities in the field of Enabling Technologies & Medical Devices starting in 2026. “Together, we are creating new opportunities for our members and strengthening the ecosystem around medical technology,” says Jan Thalens, board member of SpringBoard . About LIFE Cooperative LIFE Cooperative promotes innovation in the life sciences by facilitating collaboration between entrepreneurs, researchers, and investors. Through various programs and events, LIFE fosters the development of technologies that improve health and well-being. The cooperative represents more than 60 companies in the Northern Netherlands — from ambitious startups and innovative SMEs to international players. Together, they account for approximately 5,000 FTEs and a turnover of €500 million. About SpringBoard SpringBoard is an independent industry association for medical technology, founded in 2008 as an initiative by former employees of Cordis Roden. The network has grown to about 65 members and promotes innovation and knowledge sharing, supports entrepreneurs, and assists in setting up new companies. SpringBoard has contributed to the creation of seven new companies and around 100 jobs. Through workshops, networking events, and an open innovation platform, SpringBoard strengthens the MedTech sector and the development of human capital in the Northern Netherlands.
.jpg)
A highlight of the conference was the presentation of two royal honors (Officer in the Order of Orange-Nassau) by Groningen Mayor Roelien Kamminga to two former board members of the LIFE Cooperative, Ton Vries and Johannes Wolters. They received this recognition for their exceptional contributions to the organization and to science. "We look back with great pride on this special edition. The royal honors for our former board members Ton Vries and Johannes Wolters are a well-deserved recognition of two careers marked by dedication and entrepreneurship in the Life Science, Health & MedTech sector in Northern Netherlands. Thanks to their vision and commitment, the LIFE Cooperative stands strong today, and we continue to build on the solid foundation they laid," said Peter Ketelaar, board member of the LIFE Cooperative. Conference Highlights The conference featured a rich program, including a presentation of the LIFE Cooperative’s Industry Agenda in development. Inspiring keynotes were delivered by international scientists such as Prof. Jochen Mierau (UMCG, Lifelines) and Annelies de Lange (VIG, Association of Innovative Medicines), who shared new insights on sustainable innovations in health and care. The four companies nominated for the Innovation Award (MemoryLab, QT Sense, Sabiad, and CC Diagnostics) delivered their pitches in a thrilling finale. CC Diagnostics from Groningen emerged as the winner, receiving the €7,500 prize from Linda Dijkshoorn, board member of the LIFE Cooperative. About the LIFE Cooperative The LIFE Cooperative promotes innovation in the life sciences by facilitating collaboration between entrepreneurs, researchers, and investors. Through various programs and events, LIFE supports the development of technologies that improve health and well-being. The cooperative represents over 60 companies, ranging from ambitious startups and innovative SMEs to international players. Together, they employ over 4,750 FTEs and generate €500 million in revenue. The LIFE Science Conference is an initiative of the LIFE Cooperative and is made possible by the municipalities of Groningen and Assen, Health~Holland, NV NOM, the WEST Business Association, and various other partners and sponsors.
Read more
The LIFE Cooperative strengthens the position of its members in the Life Sciences & Health sector by facilitating networking and collaboration, providing access to talent, knowledge, facilities and financing, stimulating innovation and sustainable employment, as well as representing the interests of its members with stakeholders such as policy makers, institutions, investors and suppliers.
The LIFE Cooperative was founded in 2014 by and for northern entrepreneurs in the Life Sciences and Health sector, with the aim of promoting innovation and sustainable employment.
Over the past 10 years, the LIFE Cooperative has grown into the regional example of the united power of entrepreneurs. More than €50 million in investments and more than 500 new, high-quality jobs were created through a number of iconic projects.
Do you have a question or comment? We’re here to help. Type your message next to this or get in touch with Selma:
Project Leader
Chair of the board
Business Developer
Project Leader
Business Developer
Communication Manager
Content, Creative & Events
